Quarterly ResultJul 31, 2026, 11:48 AM
Stryker Q2 Net Sales $6.59B, Net Earnings $1.28B, EPS $3.30
AI Summary
Stryker Corporation reported strong financial results for the second quarter and first six months of 2026. For Q2 2026, net sales increased 9.4% to $6.59 billion, net earnings surged 44.3% to $1.28 billion, and diluted EPS grew 44.1% to $3.30. The company also completed the acquisition of Amplitude Vascular Systems (AVS) for $435 million in cash and potential milestone payments, and repaid $1.0 billion in senior unsecured notes.
Key Highlights
- Q2 2026 net sales increased 9.4% to $6.59 billion from $6.02 billion in Q2 2025.
- Q2 2026 net earnings rose 44.3% to $1.28 billion, up from $884 million in Q2 2025.
- Q2 2026 diluted EPS grew 44.1% to $3.30, compared to $2.29 in Q2 2025.
- Six-month 2026 net sales increased 6.1% to $12.61 billion from $11.89 billion in 2025.
- Six-month 2026 net earnings rose 31.4% to $2.02 billion, up from $1.54 billion in 2025.
- Net cash provided by operating activities for six months 2026 was $1.84 billion, a 35.3% increase.
- Acquired Amplitude Vascular Systems (AVS) in May 2026 for $435 million cash and up to $400 million in milestones.
- Repaid $1.0 billion of 3.500% senior unsecured notes in March 2026.
Price Impact
More from SYK